About Dr Michael Parkinson

BSc, MBBS, MMed (Metabolic Health), FRACP

Dr Parkinson is a consultant interventional Cardiologist, raised in Sydney’s Northern Beaches. He completed his Bachelor of Science (Physics) and post-graduate Bachelor of Medicine/Bachelor of Surgery at the University of Sydney. He undertook physician training at Royal North Shore Hospital, and specialist cardiology training though the Central Coast and Northern Sydney health networks to attain his Fellowship of the Royal Australasian College of Physicians. He completed further dedicated training in cardiac intervention and treatment of coronary disease (stenting) through an interventional fellowship at St Vincent’s Hospital, Sydney. He was then awarded the CSANZ scholarship for the UK Interventional Fellowship, which he completed at Wythenshawe Hospital in Manchester, one of the top three busiest hospitals for coronary intervention in the United Kingdom.

In addition to his interventional fellowships, Dr Parkinson has completed a post graduate Master of Medicine (Metabolic Health), which has strengthened his passion for the prevention and treatment of coronary artery disease. Dr Parkinson has a strong focus on patient-centered care and individualising treatment for each patient’s needs. He has authored and contributed to a number of publications and has presented his cardiac research at both national and international conferences.

Outside of work, Dr Parkinson enjoys playing tennis with his wife and enjoying the outdoors of Northern Sydney and the Central Coast.

Qualifications

  • University of Sydney

  • University of Sydney

  • University of Sydney

  • Adult Medicine Division, Specialist Cardiologist

Publications

§ Cardiac Myeloid Sarcoma: A 1-kg Heart. Paul Bamford, Kelsey E. Gardiner, Michael D. Parkinson, Kendall Bailey, and Maged William. J Am Coll Cardiol Case Rep. 2021 Jun, 3 (6) 963–965

§ Oral Presentation TCT conference (USA) – Sudden Hypotension –  A Sign of Aortic Dissection during Self-Expandable Transcatheter Aortic Valve Implantation, September 2020.

§ Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis. Monjur MR, Said CF, Bamford P, Parkinson M, Szirt R, Ford T. Open Heart 2020;7:e001394. doi: 10.1136/openhrt-2020-001394

§ 901 Thrombocytopenia Risk Following Glycoprotein IIB/IIIA Inhibitor use for ST-Elevation Myocardial Infarction (STEMI); A. Bland, C. Said, S. Casinader, E. Coote, M. Parkinson; Abstract for CSANZ in Heart, Lung and Circulation , Volume 29, S2, S441-S442; November 08, 2020

§ 505 Influence of Culprit Vessel and Reperfusion Strategy on Clinical Outcomes in ST-Elevation Myocardial Infarction (STEMI); C. Said, S. Casinader, A. Bland, P. Bamford, E. Coote, P. Mikhail, M. Parkinson, T. Ford; Abstract for CSANZ in Heart, Lung and Circulation , Volume 29, S2, S441-S442; November 08, 2020

§ 566 Thromboloysis for ST-Elevation Myocardial Infarction (STEMI) in Elderly Patients: Real World Outcomes in Half Strength Dosing; C. Said, S. Casinader, A. Bland, N. Howden, E. Coote, T. Ford; Abstract for CSANZ in Heart, Lung and Circulation , Volume 29, S2, S441-S442; November 08, 2020

§ 541 Reperfusion Strategy and Infarct Size in ST-Elevation Myocardial Infarction (STEMI); C. Said, A. Bland, S. Casinader, E. Coote, J. Colgan, T. Ford Abstract for CSANZ in Heart, Lung and Circulation , Volume 29, S2, S441-S442; November 08, 2020

§ Biodegradable Polymer Sirolimus Eluting Stent (Orsiro) versus Second Generation Durable Polymer Drug Eluting Stents: a meta-analysis of randomised trials. Monjur, M; Said, C; Bamford, P; Parkinson, M; Szirt, R; Ford,T; abstract for ACC, Journal of the American College of Cardiology 75(11):1331,  March 2020

§ Follow-up outcomes of pre-hospital thrombolysis and primary PCI in outer metropolitan management of STEMI. Parkinson, M. Gunalingam, B et al. Accepted as a mini oral presentation for CSANZ conference 2019

§ FFR guided deferral of PCI is safe in a mixed stable angina and ACS cohort– a regional centre experience. Parkinson, M. Spina, R et al. Accepted as a poster for ANZET conference 2019

§ Is incorrect anti-coagulation dosing contributing to ischaemic stroke burden? A retrospective single-centre study from regional New South Wales, Australia. Bamford, P. Parkinson, M. Trappel, J. Ray, M. O’Brien, W. Rogers, J. Accepted as a poster for the International Heart and Stroke Conference of the European Society of Cardiology, Berlin 2019

§  A New Era for Rotational Atherectomy: An Australian Perspective. Bamford, P. Parkinson, M. Gunalingam, B. David, M. Lau, G. Clinical Medicine Insights: Cardiology.  2019 Jun 7;13:1179546819852070.

§ Long-term outcomes after delayed angiograms in patients with successfully thrombolysed ST elevation myocardial infarctions. Said, C. Parkinson, M et al. Accepted as an abstract for CSANZ conference 2019

§ Patients with ST elevation myocardial infarction: long-term outcomes post thrombolysis in patients found to have non-obstructive coronary artery disease. Said, C. Parkinson, M et al. Accepted as an abstract for CSANZ conference 2019

§ Evaluating gender disparities in safety outcomes after pharmaco-invasive strategy vs primary PCI for ST elevation myocardial infarction: a four year analysis in two regional centres. Bamford, P. Parkinson, M et al. Accepted as an abstract for CSANZ conference 2019

§ Three-Point Rapid Rule Out for Acute Chest Pain in the Emergency Department. Cheruvu, S. Parkinson, M et al. Accepted as an abstract for CSANZ conference, 2019

§ Clinical Assessment Compared To Modified HEART Score in the Assessment of Acute Chest Pain. Cheruvu, S. Parkinson, M et al. Accepted as an abstract for CSANZ conference 2019

§ Outcomes of ST Elevation Myocardial Infarctions In Those With and Without Standard Modifiable Cardiovascular Risk Factors (SMuRFs). Cheruvu, S. Parkinson, M et al. Accepted as an abstract for CSANZ conference 2019

 

§ The Incidence of Incorrect Direct-Acting Oral Anticoagulant Dosing and Associated Iron Deficiency in Hospitalised Cardiac Patients. Parkinson, M. Bamford, P. Touma, F. Rogers, J. Forsyth, C. Abstract for CSANZ in Heart, Lung and Circulation , Volume 27 , S351, 2018

§ Staphylococcus aureus Pericarditis Presenting as Cardiac Tamponade Caused by Diabetic Foot Osteomyelitis. Bart, N. Parkinson, M. Hungerford, S. Brennan, X. Gunalingam, B. Abstract for CSANZ  Heart, Lung and Circulation , Volume 27 , S275, 2018